Literature DB >> 7085624

DNA primase activity from human lymphocytes. Synthesis of oligoribonucleotides that prime DNA synthesis.

B Y Tseng, C N Ahlem.   

Abstract

A fraction has been prepared from extracts of a human lymphoblastoid cell line that has properties of a mammalian DNA primase and also contains a DNA polymerase activity with unusual properties. With a variety of synthetic single-stranded DNA templates using rNTPs alone, the products consist of oligoribonucleotides of a restricted size range, primarily 7 to 9 nucleotides in length. Poly(dIT) is the most active template found thus far. The activity appears to have "relaxed" substrate/template complementarity requirements similar to those described previously for mammalian primase; poly(dIT) template with rATP alone results in synthesis of oligo(rA) of the same size as oligo(rAC) made when both rATP and rCTP are present. When dNTPs are added to the reaction, DNA is synthesized by extension of the oligoribonucleotide, which acts as primer. The DNA product appears in relatively discrete sizes that differ by approximately 8 nucleotides, with a large proportion of the product around 24 and 32 nucleotides. In addition to the relatively discrete size of its product, the DNA polymerase activity that utilizes the endogenously synthesized oligoribonucleotide primer on poly(dIT) template differs from polymerase alpha in its resistance to aphidicolin and low Km for dNTP.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7085624

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Pea chloroplast DNA primase: characterization and role in initiation of replication.

Authors:  B L Nielsen; V K Rajasekhar; K K Tewari
Journal:  Plant Mol Biol       Date:  1991-06       Impact factor: 4.076

2.  Sequence and structural requirements for primase initiation in the SV40 origin of replication.

Authors:  B Y Tseng; C E Prussak
Journal:  Nucleic Acids Res       Date:  1989-03-11       Impact factor: 16.971

3.  Identification and characterization of a DNA primase activity present in herpes simplex virus type 1-infected HeLa cells.

Authors:  A M Holmes; S M Wietstock; W T Ruyechan
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

4.  Selection of template initiation sites and the lengths of RNA primers synthesized by DNA primase are strongly affected by its organization in a multiprotein DNA polymerase alpha complex.

Authors:  J K Vishwanatha; M Yamaguchi; M L DePamphilis; E F Baril
Journal:  Nucleic Acids Res       Date:  1986-09-25       Impact factor: 16.971

5.  Resolution and purification of free primase activity from the DNA primase-polymerase alpha complex of HeLa cells.

Authors:  J K Vishwanatha; E F Baril
Journal:  Nucleic Acids Res       Date:  1986-11-11       Impact factor: 16.971

6.  Characterization of a temperature-sensitive mutant of mouse FM3A cells defective in DNA replication.

Authors:  Y Murakami; H Yasuda; H Miyazawa; F Hanaoka; M Yamada
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

7.  Initiation of simian virus 40 DNA replication in vitro: aphidicolin causes accumulation of early-replicating intermediates and allows determination of the initial direction of DNA synthesis.

Authors:  R S Decker; M Yamaguchi; R Possenti; M L DePamphilis
Journal:  Mol Cell Biol       Date:  1986-11       Impact factor: 4.272

8.  Mouse primase initiation sites in the origin region of simian virus 40.

Authors:  B Y Tseng; C N Ahlem
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

9.  Discontinuous DNA replication of Drosophila melanogaster is primed by octaribonucleotide primer.

Authors:  T Kitani; K Yoda; T Okazaki
Journal:  Mol Cell Biol       Date:  1984-08       Impact factor: 4.272

10.  Mouse DNA polymerase alpha-primase terminates and reinitiates DNA synthesis 2-14 nucleotides upstream of C2A1-2(C2-3/T2) sequences on a minute virus of mice DNA template.

Authors:  E A Faust; R Nagy; S K Davey
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.